Kits Eyecare (KITS) News Today

Kits Eyecare Ltd (TSE:KITS) is trading lower after a wave of analyst price‑target cuts this week even as several firms reaffirm buy ratings. Trading volume is running above average, suggesting heavier selling interest. Investors are reacting to mixed signals: analysts still see meaningful upside from current levels but lowered targets and modest quarterly results are weighing on near‑term sentiment.

• Positive Sentiment: Haywood reiterated a buy on KITS and framed recent share weakness as a buying opportunity, maintaining a higher price target (reported coverage). Analyst Maintains Buy on KITS
• Neutral Sentiment: Q1 results: KITS reported C$0.06 EPS and C$57.47M revenue. The release did not produce a clear catalyst to reverse the selloff and investors will look to guidance/metrics from the call and slide deck for directional cues. Earnings Release & Call
• Negative Sentiment: Canaccord lowered its price target to C$22.00 (still a buy) — the cut reduces upside expectations and likely contributed to selling pressure. BayStreet Coverage
• Negative Sentiment: ATB Cormark trimmed its target to C$16.75 and labeled the stock a "speculative buy," signaling more conservative near‑term expectations. BayStreet Coverage
• Negative Sentiment: Desjardins cut its target to C$23.00 while keeping a buy rating — another downward revision that dampens momentum. BayStreet Coverage
• Negative Sentiment: Stifel lowered its target to C$21.00 (buy), adding to the cluster of PT cuts pressuring the stock. BayStreet Coverage

What to watch: analyst note updates and whether management provides stronger guidance on same‑store sales, margins or clinic expansion on the recent conference call/slide deck. The mix of maintained buy ratings (positive) and across‑the‑board target trims (negative) explains the down move: analysts still see upside longer term, but near‑term sentiment has weakened as targets were lowered and the quarter failed to provide a clear upside catalyst.